Korean Society of Interventional Cardiology Expert Consensus for the Management of Chronic Coronary Syndrome: Part 2

Revascularization remains an important component of chronic coronary syndrome (CCS) management, particularly in patients with high-risk coronary anatomy, impaired left ventricular (LV) function, or persistent symptoms despite guideline-directed medical therapy. Evidence indicates that prognostic benefit is most pronounced in patients with left main disease, multivessel disease, proximal left anterior descending artery involvement, and severe LV systolic dysfunction. In other patients, revascularization primarily improves angina symptoms and quality of life. The choice between percutaneous coronary intervention (PCI) and coronary artery bypass grafting should be individualized according to coronary anatomy, clinical risk, comorbidities, and the likelihood of complete revascularization. Contemporary PCI increasingly incorporates coronary physiology and intravascular imaging to refine lesion selection and improve procedural outcomes. Long-term CCS management requires structured follow-up to detect disease progression, recurrent ischemia, revascularization failure, and cardiovascular complications. Routine surveillance testing is not recommended in asymptomatic patients after PCI. Instead, follow-up should be tailored to patient risk and clinical status. When complete revascularization fails, mechanisms such as stent thrombosis, in-stent restenosis, graft failure, and progression of untreated coronary disease should be identified; intravascular imaging has an important role in guiding repeat revascularization. Comprehensive CCS management should also address complications, including heart failure, ventricular arrhythmias, and secondary valvular disease, through a multidisciplinary, patient-centered approach.